Research and Markets: Male Sexual Dysfunction Global Clinical Trials Review, H2, 2015

Research and Markets (http://www.researchandmarkets.com/research/xvknpj/male_sexual) has announced the addition of the "Male Sexual Dysfunction Global Clinical Trials Review, H2, 2015" report to their offering.

This new report provides an overview of Male Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Male Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report provides:

• A snapshot of the global clinical trials landscape.
• Top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status.
• A reviews of the top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
• All the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment.
• Enrollment trends for the past five years.
• Latest news for the past three months.
  

Reasons to buy:

• Assists in formulating key business strategies with regards to investment.
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities.
• Supports understanding of trials count and enrollment trends by country in global therapeutics market.
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials.
• Facilitates clinical trial assessment of the indication on a global, regional and country level.
  

Companies Mentioned:

• Bayer AG
• Pfizer Inc.
• Eli Lilly and Company
• GlaxoSmithKline Plc
• Vivus, Inc.
• Dong-A Socio Group
• Johnson & Johnson
• SK Chemicals Co., Ltd.
• Plethora Solutions Holdings Plc
• Allergan Plc

For more information visit http://www.researchandmarkets.com/research/xvknpj/male_sexual

View source version on businesswire.com: http://www.businesswire.com/news/home/20151126005520/en/